Found: 16
Select item for more details and to access through your institution.
Fibrotic Signaling in Cardiac Fibroblasts and Vascular Smooth Muscle Cells: The Dual Roles of Fibrosis in HFpEF and CAD.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 10, p. 1657, doi. 10.3390/cells11101657
- By:
- Publication type:
- Article
The potent AMPK inhibitor BAY-3827 shows strong efficacy in androgen-dependent prostate cancer models.
- Published in:
- Cellular Oncology (2211-3428), 2021, v. 44, n. 3, p. 581, doi. 10.1007/s13402-020-00584-8
- By:
- Publication type:
- Article
Dysregulated Transcriptional Control in Prostate Cancer.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 12, p. 2883, doi. 10.3390/ijms20122883
- By:
- Publication type:
- Article
Recent Advances in Prostate Cancer Treatment and Drug Discovery.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 5, p. 1359, doi. 10.3390/ijms19051359
- By:
- Publication type:
- Article
Exploiting Epigenetic Alterations in Prostate Cancer.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 5, p. 1017, doi. 10.3390/ijms18051017
- By:
- Publication type:
- Article
Dual targeting of the androgen receptor and PI3K/AKT/mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosis.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 3, p. 726, doi. 10.1002/1878-0261.13577
- By:
- Publication type:
- Article
Darolutamide antagonizes androgen signaling by blocking enhancer and super‐enhancer activation.
- Published in:
- Molecular Oncology, 2020, v. 14, n. 9, p. 2022, doi. 10.1002/1878-0261.12693
- By:
- Publication type:
- Article
MACA: marker-based automatic cell-type annotation for single-cell expression data.
- Published in:
- Bioinformatics, 2022, v. 38, n. 6, p. 1756, doi. 10.1093/bioinformatics/btab840
- By:
- Publication type:
- Article
Histone Chaperone SSRP1 is Essential for Wnt Signaling Pathway Activity During Osteoblast Differentiation.
- Published in:
- Stem Cells, 2016, v. 34, n. 5, p. 1369, doi. 10.1002/stem.2287
- By:
- Publication type:
- Article
Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsiveness.
- Published in:
- EMBO Reports, 2018, v. 19, n. 10, p. 1, doi. 10.15252/embr.201846783
- By:
- Publication type:
- Article
Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsiveness.
- Published in:
- EMBO Reports, 2016, v. 17, n. 11, p. 1609, doi. 10.15252/embr.201642352
- By:
- Publication type:
- Article
CHD1 regulates cell fate determination by activation of differentiation-induced genes.
- Published in:
- Nucleic Acids Research, 2017, v. 45, n. 13, p. 7722, doi. 10.1093/nar/gkx377
- By:
- Publication type:
- Article
BRD4 localization to lineage-specific enhancers is associated with a distinct transcription factor repertoire.
- Published in:
- Nucleic Acids Research, 2017, v. 45, n. 1, p. 127, doi. 10.1093/nar/gkw826
- By:
- Publication type:
- Article
Comparative Proteomic and Transcriptomic Analysis of the Impact of Androgen Stimulation and Darolutamide Inhibition.
- Published in:
- Cancers, 2023, v. 15, n. 1, p. 2, doi. 10.3390/cancers15010002
- By:
- Publication type:
- Article
RNF40 regulates gene expression in an epigenetic context-dependent manner.
- Published in:
- Genome Biology, 2017, v. 18, p. 1, doi. 10.1186/s13059-017-1159-5
- By:
- Publication type:
- Article
Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer models.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 5, p. 1382, doi. 10.1002/ijc.32242
- By:
- Publication type:
- Article